Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls

Cognitive dysfunction is common in depression during both acute episodes and remission. Vortioxetine is a novel multimodal antidepressant that has improved cognitive function including executive function in depressed patients in randomised placebo-controlled clinical trials. However, it is unclear w...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, J, Browning, M, Conen, S, Smallman, R, Buchbjerg, J, Larsen, K G, Olsen, C K, Christensen, S R, Dawson, G R, Deakin, J F, Hawkins, P, Morris, R, Goodwin, G, Harmer, C J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984095/
https://www.ncbi.nlm.nih.gov/pubmed/28533517
http://dx.doi.org/10.1038/mp.2017.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984095/
https://www.ncbi.nlm.nih.gov/pubmed/28533517
http://dx.doi.org/10.1038/mp.2017.104

Ejemplares similares